Literature DB >> 16845625

Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York.

Amneris E Luque1, Musaret Jabeen, Susan Messing, Christopher A Lane, Lisa M Demeter, Robert C Rose, Richard C Reichman.   

Abstract

Women with human immunodeficiency virus (HIV) infection have higher rates of concurrent human papillomavirus (HPV) infection and cervical dysplasia than do HIV-uninfected women. They are also more commonly infected with multiple HPV types simultaneously. To determine the prevalence of different HPV genotypes in a group of HIV-infected women and to correlate these findings with cervical cytological results, we studied a group of 229 women attending a university-based HIV clinic during a 7-year period. When cervicovaginal lavage specimens, the reverse line-blot assay, and DNA sequencing were used, the most commonly detected HPV types (in decreasing order of frequency) were 56, 53, 16, 58, 52, MM7, MM8, and 33. These results contrast sharply with similar studies of HIV-uninfected women, in whom HPV-16 and -18 generally predominate. In our study, the HPV types most commonly associated with low-grade squamous intraepithelial lesions (SILs) were 56 and 53. Types most commonly associated with high-grade SILs were 52 and 58. High-risk HPV types other than 16 and 18 are often found in HIV-infected women and are frequently associated with abnormal cervical cytological results in this setting. These observations have implications for the design of future HPV vaccines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845625     DOI: 10.1086/505876

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.

Authors:  Iain J Macleod; Belinda O'Donnell; Sikhulile Moyo; Shahin Lockman; Roger L Shapiro; Mukendi Kayembe; Erik van Widenfelt; Joseph Makhema; M Essex; Carolyn Wester
Journal:  J Med Virol       Date:  2011-10       Impact factor: 2.327

2.  Human papillomavirus genotype distribution among human immunodeficiency virus (HIV)-infected and non-HIV-infected women in Soweto, South Africa.

Authors:  David Adler; Guy de Bruyn; Fatima Laher; Glenda Gray; Bruce R Allan; Anna-Lise Williamson
Journal:  J Clin Microbiol       Date:  2008-10-22       Impact factor: 5.948

3.  Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection.

Authors:  Christof Geldmacher; Richard A Koup
Journal:  Trends Immunol       Date:  2012-03-05       Impact factor: 16.687

4.  Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN).

Authors:  Amneris E Luque; Jane Hitti; Christina Mwachari; Christopher Lane; Susan Messing; Susan E Cohn; David Adler; Robert Rose; Robert Coombs
Journal:  Int J Infect Dis       Date:  2010-07-22       Impact factor: 3.623

5.  Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.

Authors:  Jennifer R Moodley; Deborah Constant; Margaret Hoffman; Anna Salimo; Bruce Allan; Ed Rybicki; Inga Hitzeroth; Anna-Lise Williamson
Journal:  BMC Cancer       Date:  2009-08-07       Impact factor: 4.430

6.  Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa.

Authors:  Andrew J Desruisseau; Delf Schmidt-Grimminger; Edith Welty
Journal:  Infect Dis Obstet Gynecol       Date:  2010-02-09

7.  Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.

Authors:  Kenneth H Fife; Julia W Wu; Kathleen E Squires; D Heather Watts; Janet W Andersen; Darron R Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

Review 8.  Human papillomavirus vaccination in HIV-infected women: need for increased coverage.

Authors:  Erna Milunka Kojic; Aadia I Rana; Susan Cu-Uvin
Journal:  Expert Rev Vaccines       Date:  2015-11-24       Impact factor: 5.217

9.  Prevalence of High Risk HPV in HIV-Infected Women From Belém, Pará, Amazon Region of Brazil: A Cross-Sectional Study.

Authors:  Jacqueline Cortinhas Monteiro; Ricardo Roberto de Souza Fonseca; Tuane Carolina de Sousa Ferreira; Luana Lorena Silva Rodrigues; Andreza Reis Brasil da Silva; Samara Tatielle Gomes; Rodrigo Vellasco Duarte Silvestre; Andréa Nazaré Monteiro Rangel Silva; Ilze Pamplona; Antonio Carlos Rosário Vallinoto; Ricardo Ishak; Luiz Fernando Almeida Machado
Journal:  Front Public Health       Date:  2021-04-29

10.  HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.

Authors:  Michael Odida; Sven Sandin; Florence Mirembe; Bernhard Kleter; Wim Quint; Elisabete Weiderpass
Journal:  Infect Agent Cancer       Date:  2011-06-25       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.